Stock Analysis
Colgate-Palmolive CompanyCL
P/E 36.81×· 5Y range 20.95–47.11×· top 19% of history
Sector: Consumer Defensive · Industry: Perfumes, Cosmetics & Other Toilet Preparations
AnalystsBuy31 analystsP/E 36.8× sits at the 81st percentile of its 5.0978781656399725-year history.
Cash covers 18% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, expensive valuation
Strengths
- Quality90
- Profitability75
Risks
- Valuation45
- Growth37
Mixed fundamentals at a demanding price.
Bull Case
- ✓Altman Z 6.1 — safe-zone balance sheet
- ✓ROE 360.1% — efficient capital deployment
- ✓Interest coverage 18.8× — debt well covered
What's happening with CL
Profile
Strong moat, earnings quality and profitability; growth and valuation lag behind.
How is each axis scored?
- Valuation45/100 · Weak
- P/E vs own history (81th pct)0/25
- FCF yield (5.1%)20/25
- P/S (3.6x)20/25
- EV/EBIT (26.1x)5/25
- Growth37/100 · Weak
- Revenue CAGR (4.0%)6/25
- Net income CAGR (-0.4%)0/25
- EPS CAGR 5Y (0.8%)6/25
- Fwd implied growth (71.7%)25/25
- Profitability75/100 · Strong
- ROIC (35.5%)25/25
- ROE (360.1%)25/25
- Net margin (9.7%)13/25
- Operating margin (14.9%)12/25
- Financial Health67/100 · Moderate
- Altman Z (6.10)25/25
- Current ratio (1.03)12/25
- Interest coverage (18.8x)25/25
- Net cash / debt (D/A 38%)5/25
- Quality90/100 · Strong
- Piotroski F (6/9)15/25
- Beneish M (-3.03)25/25
- FCF conversion (189%)25/25
- Margin stability (σ 3.1%)25/25
- Moat93/100 · Strong
- ROIC >12% years (10/10 yrs)25/25
- Median gross margin (59.8%)25/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 9.9%)18/25
Risk Flags
- ⚠P/E 36.8× at top 19% of 5-year history
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. Show more
In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
Headquarters: NEW YORK, NY · Employees: 33,600 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
45D+P/E (TTM)37.0xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 20.9x–47.1x · 81st pct
P/FCF19.5xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield5.1%A
Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 3.2%–5.7% · 84th pct
P/S (TTM)3.58xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 3.0x–4.5x · 44th pct
EV/EBIT26.1xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 15.7x–26.3x · highest in history
EV/Sales3.9xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E21.5xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio133.09xD
Grade D: Very expensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio6.31D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield2.43%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio62.6%C
Grade C: HighDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
75B+ROIC35.5%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE360.1%A
Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks
ROA12.1%A
Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin9.7%C
Grade C: AverageNet Income / Revenue
Operating Margin14.9%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin60.4%A
Grade A: PremiumGross Profit / Revenue
FCF Margin18.3%A
Grade A: HighFCF / Revenue
True FCF Margin17.5%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
37DRevenue CAGR4.0%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR-0.4%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)0.8%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth71.7%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-6.1%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income8.7%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.8%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
67BAltman Z-Score6.10A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.03xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio0.67xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage18.8xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment1.7yA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBIT2.0xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity13.88xD
Grade D: HighDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.18xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
90A+Piotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-3.03A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion189.3%A
Grade A: StrongFCF / Net Income
Margin Stability3.1%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue2.8%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover1.25xA
Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Newman Brian Filed | Newman Brian | Grant / award | +214 | |
BILBREY JOHN P Filed | BILBREY JOHN P | Grant / award | +271 | |
NORRINGTON LORRIE M Filed | NORRINGTON LORRIE M | Grant / award | +300 | |
Fishbone Betsy Filed | Fishbone Betsy | Grant / award | +15.3K | |
Fishbone Betsy Filed | Fishbone Betsy | Grant / award | +2.2K |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Hazlin John Filed | Hazlin John | Grant / award | +27.0K | |
Hazlin John Filed | Hazlin John | Grant / award | +3.9K | |
GRANT SHANE Filed | GRANT SHANE | Grant / award | +50.9K |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
93A+ROIC >12% Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)59.8%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor9.9%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$2.56
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$1.82
Cash & short-term investments per share (Finnhub)
Book Value / Share$0.30
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$7.86B
Total debt obligations (short + long term)
Cash & Equiv.$1.45B
Cash and short-term investments
Net Debt$6.40B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$566.00M
Shareholders' equity (book value)
Asset / Liability1.03xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$75.33B
Current Market Capitalization
Beta0.33B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Colgate-Palmolive Company (CL)
CL is up 1.55% at the last close. Piotroski F-Score of 6/9 indicates mixed fundamentals for Colgate-Palmolive Company. Altman Z-Score of 6.10 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of -3.03 suggests a low likelihood of earnings manipulation.
- Colgate-Palmolive Company converts about 18% of revenue into free cash flow — strong cash generation.
- Takes ~1.7 years to repay net debt from free cash flow.
- Return on equity of 360.1% is well above the market average.
- The stock currently yields 2.4% in dividends.
See how CL ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all CL moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 14 | Regular | 92.06 | +2.35% | 2.07 |
| Oct 14 | After-hours | 92.40 | +2.72% | 2.42 |
| Oct 5 | Regular | 86.08 | +2.16% | 2.96 |
| Oct 5 | After-hours | 86.13 | +2.22% | 3.03 |
Frequently Asked Questions about CL
What is the current Colgate-Palmolive Company (CL) stock price?
CL is trading at $94.11 at the last market close, up 1.55% on the session. PreMarketPrice tracks CL pre-market, intraday and after-hours prices.
Is CL stock a buy right now?
PreMarketPrice's quantitative model rates Colgate-Palmolive Company's financial health at 67/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is CL stock overvalued?
Colgate-Palmolive Company trades at a trailing P/E of 37.0 and our valuation score rates it 45/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Colgate-Palmolive Company report earnings?
No confirmed earnings date is currently scheduled for CL. The Earnings section lists recent reports and updates as dates are announced.
What sector does Colgate-Palmolive Company operate in?
Colgate-Palmolive Company operates in the Consumer Defensive sector, within the Perfumes, Cosmetics & Other Toilet Preparations industry. The Related Stocks section lists sector peers for comparison.
What does Colgate-Palmolive Company do?
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry.
About Colgate-Palmolive Company (CL) Stock
Colgate-Palmolive Company (CL) is a US-listed stock operating in the Consumer Defensive sector, specifically the Perfumes, Cosmetics & Other Toilet Preparations industry. As of the latest update, Colgate-Palmolive Company is trading at $94.11, up 1.55% on the day with a market capitalization of $75.3 billion. The financial health score for CL is 67/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for CL stock.
CL Stock Analysis & Key Metrics
On PreMarketPrice, you can track Colgate-Palmolive Company (CL) across multiple dimensions:
- Pre-market price & movement: Real-time CL stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for CL with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Colgate-Palmolive Company across multiple reporting periods.
- Financial health score: A composite score of 67/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for CL.
- Sector peers: Compare CL against 5 other consumer defensive stocks on key financial metrics.
Is CL a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Colgate-Palmolive Company (CL) as an investment. The financial health score of 67/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Colgate-Palmolive Company (CL) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.